SA:003/25
|
|
Updated: Anticipated disruption to supply of multiple antiseptic products | 4 April 2025 | 21 May 2025 |
SA:002/25
| |
Managing the shortage of neonatal and paediatric endotracheal tubes | 7 March 2025 | 19 May 2025 |
| SA:001/25 |
|
Suspected botulism following cosmetic injections | 24 January 2025 | 15 May 2025 |
| SN:022/24 |
|
Updated: Mpox is spreading across NSW | 8 August 2024 | 15 May 2025 |
| SN:012/24 |
|
Middle Eastern Respiratory Syndrome | 20 June 2024 | 15 May 2025 |
| SA:005/24 |
|
Clinician Alert – Rabies Risk for Timor-Leste | 28 March 2024 | 15 May 2025 |
| SA:003/24 |
|
Updated: Clinician Alert - Legionella pneumophilia | 23 February 2024
| 15 May 2025 |
| SI:008/23 |
|
Updated: Reporting Adverse Events Following Immunisation | 23 May 2023
| 15 May 2025 |
| SN:004/23 |
|
Clinician Alert – Foodborne Botulism | 22 February 2023 | 15 May 2025 |
| SA:002/23 |
|
Updated: Defect alert: Computerised Ambulatory Delivery Device (CADD) Infusion pump disposables | 12 January 2023 | 15 May 2025 |
| SI:013/22 |
|
Increased incidence of invasive meningococcal disease | 19 December 2022 | 15 May 2025 |
| SN:023/23 |
|
Disruption to supply – Lidocaine (lignocaine) 1% (50 mg/5 mL) and 2% (100 mg/5 mL) solution for injection (Pfizer and Baxter) | 23 August 2023
| 2 May 2025 |
SI:006/25
|
|
Clinician Alert - Antimicrobial resistant gonorrhoea
| 7 April 2025
| 24 April 2025 |
SN:006/25
|
|
Concerns regarding Achromobacter contamination of antiseptic products | 20 March 2025 | 4 April 2025 |
SI:010/24
|
|
Clinician Alert - Measles in NSW
| 20 December 2024
| 17 March 2025 |
SI:001/25
|
|
Prevention of infection transmission to and from health care workers
| 17 February 2025
| 11 March 2025 |
| SN:016/22 |
|
Adaptors for administration of bronchodilators using metered dose inhalers via endotracheal tubes | 7 October 2022 | 12 February 2025 |
| SI:003/23 |
|
HIV Post Exposure Prophylaxis in Emergency Departments and Sexual Health Services | 10 February 2023 | 12 February 2025 |
| SN:011/22 |
|
Strong opioids detected in counterfeit ‘Kalma’ tablets | 26 August 2022 | 12 February 2025 |
| SN:020/22 |
|
Updated: New recommendations for anticancer drug dosing in kidney dysfunction – ADDIKD guideline | 4 November 2022 | 12 February 2025 |
| SN:001/23 |
|
Disruption to supply – multiple antibiotic oral liquids | 23 January 2023 | 12 February 2025 |
| SN:026/23 |
|
Vigilance required: Increase in listeriosis cases in NSW | 8 September 2023 | 12 February 2025 |
| SN:027/24 |
|
Updated: Disruption to supply – Gentamicin (Pfizer®) 80 mg/2 mL (as sulfate) injection BP ampoule | 10 October 2024 | 6 February 2025 |
| SA:015/24 |
|
Updated: Critical disruption to the supply of multiple intravenous fluid bags | 17 October 2024 | 29 January 2025 |
SI:012/22
| |
Updated: Philips Respironics CPAP and bi-level masks containing magnets
| 16 December 2022
| 22 January 2025 |
| SI:010/22 | | Essure contraceptive devices | 10 November 2022 | 22 January 2025 |
| SN:024/22 |
| Philips 12-Lead chest lead-set defect | 5 December 2022 | 22 January 2025 |
| SN:003/22 |
| Risk of retained intubating stylet fragment in neonates | 19 April 2022 | 22 January 2025 |
| SN:005/22 |
|
Infection post cardiopulmonary bypass associated with heater cooler devices - Updated | 23 May 2022 | 21 January 2025
|
| SA:006/24 |
|
Clinician alert – Measles
| 12 April 2024 | 20 December 2024 |
| SI:001/15 |
|
E – Cigarettes, Oxygen Therapy, Burns and Fire Risk | 20 January 2015 | 19 December 2024 |
SN:005/24
|
|
Updated: Disruption to supply – Benzathine benzylpenicillin (Bicillin L-A) suspension for injection pre-filled syringe | 11 April 2024 | 19 December 2024
|
SN:026/24
|
|
Updated: Disruption to supply: Heparin sodium (Pfizer®) 5,000 units/5 mL injection ampoule | 2 October 2024 | 16 December 2024 |
| SI:013/23 |
|
Risk forecast for encephalitic flaviviruses (JEV, MVEV, KUNV) and JEV vaccination eligibility update
| 29 November 2023 | 12 December 2024 |
| SN:017/24 |
|
Prothrombin complex concentrate transition to Beriplex®: clinical considerations | 1 July 2024 | 12 December 2024 |
| SA:004/24 |
|
Updated: Critical disruption to supply – Intravenous (IV) paracetamol solution for injection/infusion | 1 March 2024 | 14 November 2024 |
| SI:008/22 |
|
Change to in-use shelf-life of Prograf®(immediate-release tacrolimus) capsules
| 6 October 2022 | 6 November 2024 |
SN:019/24
|
|
Disruption to supply - Adrenaline (epinephrine) (Aguettant®) 1:10,000 (1 mg/10 mL) pre-filled syringe | 11 July 2024 | 1 November 2024 |
| SN:022/23 |
|
Updated: Assessment and care of early labour; opioid and non-opioid analgesia | 15 August 2023 | 24 October 2024
|
| SN:027/23 |
|
Disruption to supply – tenecteplase (Metalyse®) and alteplase (Actilyse®) injection | 13 September 2023 | 22 October 2024
|
| SN:006/22 |
|
Sterile Theatre Pack’ formulations of lignocaine (lidocaine) with adrenaline (epinephrine) and bupivacaine with adrenaline (epinephrine) injection disruption to supply – Updated | 7 June 2022 | 22 October 2024
|
SN:014/24
| | Updated: Critical disruption to the supply of multiple intravenous fluid bags
| 20 September 2024
| 17 October 2024
|
SN:025/24
|
|
Updated: Disruption to supply – Azithromycin (Zithromax) 200 mg/5 mL powder for oral suspension
| 19 September 2024
| 15 October 2024
|
| SN:005/23 |
|
Potential for error: look-alike medicines presented in blue medicine bottles | 6 March 2023 | 14 October 2024
|
| SI:004/23 |
|
Potential for error: look-alike HYDROmorphone and morphine sulfate Medsurge® solution for injection | 20 February 2023 | 14 October 2024
|
| SI:002/23 |
|
Updated: Potential for error: look-alike fentanyl and suxamethonium Juno® ampoules | 31 January 2023 | 14 October 2024
|
| SN:016/24 |
|
Disruption to supply – Gentamicin (Pfizer®) 80 mg/2 mL (as sulfate) injection BP ampoule | 1 July 2024 | 10 October 2024
|
SN:004/24
|
|
Updated: Disruption to supply: Heparin sodium (Pfizer®) 5,000 units/5 mL injection ampoule
| 4 April 2024
| 2 October 2024
|
| SN:026/21 |
|
Safety risks due to new labelling of intravenous calcium gluconate | 15 December 2021 | 24 September 2024
|
SN:013/24
|
| Updated: Critical disruption to the supply of multiple intravenous fluid bags
| 6 August 2024
| 20 September 2024
|
SN:010/24
|
|
Disruption to supply – Azithromycin 200 mg/5 mL powder for oral suspension | 30 May 2024 | 19 September 2024 |
| SN:031/23 |
|
Cases of harm linked to strong opioids (nitazenes) in refillable vape (e-cigarette) liquids | 7 November 2023 | 26 August 2024 |
| SN:020/24 |
|
Mpox is spreading in NSW | 11 July 2024 | 8 August 2024 |
| SA:012/24 |
|
Updated: Critical disruption to the supply of multiple intravenous fluid bags | 30 July 2024 | 6 August 2024 |
| SA:011/24 |
|
Critical disruption to the supply of multiple intravenous fluid bags | 16 July 2024 | 30 July 2024 |
| SN:021/21 |
|
Safety risks due to new labelling on the outer carton packaging of intravenous potassium chloride ampoules | 10 September 2021 | 19 July 2024 |
| SN:007/19 |
|
High Concentration Insulin Products (Updated) (Supersedes SN:009/17) | 24 June 2019 | 19 July 2024 |
| SN:013/22 |
|
Packaging error – Zoledronic acid (Osteovan®) solution for injection vial | 28 September 2022 | 19 July 2024 |
| SN:014/24 |
|
Ongoing disruption to the supply of multiple intravenous fluid bags | 26 June 2024 | 16 July 2024 |
| SN:013/19 |
|
Incompatibility between oxygen cylinders with inbuilt regulators with Air/Oxygen Blenders | 26 September 2019 | 1 July 2024 |
| SN:008/24 |
|
Disruption to supply – Sodium chloride 0.9% 100 mL intravenous solution | 27 May 2024 | 26 June 2024 |
| SI:001/17 |
|
Choking Risk in Mental Health Consumers | 6 February 2017 | 13 June 2024 |
| SN:028/23 |
|
Discontinuation of all strengths of immediate-release morphine hydrochloride trihydrate (Ordine®) oral solution in Australia | 17 October 2023 | 21 May 2024 |
| SN:003/18 |
|
Complications Associated with Inferior Vena Cava Filters | 19 February 2018 | 13 May 2024 |
| SN:010/16 |
|
Medical gas cylinders | 10 October 2016 | 13 May 2024 |
| SN:029/23 |
|
Updated: Supply disruption: Rapid Fetal Fibronectin (fFN) 10Q cassettes | 24 October 2023 | 8 May 2024 |
| SA:002/24 |
|
Updated: Clinician alert – Measles case in NSW | 18 January 2024 | 12 April 2024 |
| SN:001/24 |
|
Updated: Disruption to supply – Benzathine benzylpenicillin (Bicillin L-A) suspension for injection pre-filled syringe | 5 March 2024 | 11 April 2024 |
| SN:009/23 |
|
Updated: Disruption to supply: Heparin sodium (Pfizer®) 5,000 units/5 mL injection ampoule | 27 April 2023 | 4 April 2024 |
| SN:012/19 |
|
Link adrenaline (epinephrine) 1 in 10,000 prefilled syringe - device failure | 23 August 2019 | 6 March 2024 |
| SN:040/23 |
|
Updated: Disruption to supply – Benzathine benzylpenicillin (Bicillin L-A) suspension for injection pre-filled syringe | 15 December 2023 | 5 March 2024 |
| SN:032/23 |
|
Disruption to supply – Intravenous (IV) paracetamol solution for injection/infusion | 10 November 2023 | 1 March 2024 |
| SA:001/24 |
|
Clinician Alert - Pneumonia – Legionella and Mycoplasma | 4 January 2024 | 23 February 2024 |
| SA:005/23 |
|
Updated: Clinician alert – Measles case in NSW | 6 April 2023 | 18 January 2024 |
| SN:043/23 |
|
Safe use of magnesium sulfate heptahydrate in maternity services | 19 December 2023 | 20 December 2023 |
| SN:002/23 |
|
Updated: Transvaginal mesh implants for Pelvic Organ (Vaginal) Prolapse | 1 February 2023 | 18 December 2023 |
| SN:039/23 |
|
Updated: Possible contamination of multiple sodium chloride products – Quarantine and recall actions | 13 December 2023 | 15 December 2023 |
| SN:036/23 |
|
Disruption to supply – Benzathine benzylpenicillin (Bicillin L-A) suspension for injection pre-filled syringe | 1 December 2023 | 15 December 2023 |
| SI:010/23 |
|
Optimisation of elastomeric infusion devices | 29 August 2023 | 14 December 2023 |
| SN:038/23 |
|
Updated: Possible contamination of multiple sodium chloride products – Quarantine and recall actions | 11 December 2023 | 13 December 2023 |
| SN:037/23 |
|
Possible contamination of multiple sodium chloride products – Quarantine and recall actions | 1 December 2023 | 11 December 2023 |
| SA:003/23 |
|
Encephalitic Flaviviruses (MVEV, JEV, KUNV) –Update for Clinicians | 23 February 2022 | 29 November 2023 |
| SN:033/23 |
|
Provision of written leave information for consumers on leave from mental health inpatient units | 22 November 2023 | 24 November 2023 |
| SN:009/18 |
|
Intragastric Balloon Systems | 6 August 2018 | 22 November 2023 |
| SN:012/18 |
|
Rupture of membranes testing in maternity settings | 20 August 2018 | 22 November 2023 |
| SN:019/18 |
|
Oxygen Cylinders with Integrated Valve Regulator | 29 November 2018 | 22 November 2023 |
| SN:010/21 |
|
Requirements for post-transplant blood-borne virus surveillance of recipients of organs from increased-risk donors | 18 May 2021 | 22 November 2023 |
| SN:019/21 |
|
Flow sensors used in selected GE healthcare / datex-ohmeda anaesthesia machines | 30 August 2021 | 22 November 2023 |
| SI:009/22 |
|
Increased universal screening for syphilis infection in pregnancy | 7 November 2022 | 22 November 2023 |
| SN:009/22 |
|
Update: Philips Sound Abatement Foam on selected sleep and respiratory devices | 27 July 2022 | 22 November 2023 |
| SN:018/23 |
|
PrisMax Continuous Renal Replacement Therapy Device: B2222 Alarm | 3 August 2023 | 22 November 2023 |
| SI:010/21 |
|
Electronic Fetal Monitoring (EFM) during water immersion | 30 November 2021 | 17 November 2023 |
| SI:006/22 |
|
Unregistered benzodiazepines and counterfeit alprazolam products in NSW | 1 August 2022 | 3 November 2023 |
| SN:008/19 |
|
Set up of neonatal resuscitaires | 24 June 2019 | 26 October 2023 |
| SN:003/23 |
|
Supply disruption: Rapid Fetal Fibronectin (fFN) 10Q cassettes | 14 February 2023 | 24 October 2023 |
| SI:002/17 |
|
Gadolinium-based contrast agents for MRI scans | 15 August 2017 | 3 October 2023 |
| SN:004/20 |
|
Lantus discontinuation and introduction of new insulin glargine products | 11 June 2020 | 3 October 2023 |
| SN:022/22 |
|
Discontinuation of Jurnista® (HYDROmorphone hydrochloride) modified release tablets in Australia | 29 November 2022 | 3 October 2023 |
| SI:001/16 |
|
Increase in Cases of Invasive Meningococcal Disease | 19 February 2016 | 21 September 2023 |
| SI:005/20 |
|
Safe use of disposable (single patient use) slings | 24 September 2020 | 21 September 2023 |
| SN:016/09 |
|
Safe Instrumental Birth | 28 July 2009 | 21 September 2023 |
| SN:006/10 |
|
Pathology Testing - Caesarean Section Operations | 16 June 2010 | 21 September 2023 |
| SN:015/11 |
|
Bathing of Newborn Babies and Infection Prevention | 22 November 2011 | 21 September 2023 |
| SA:006/23 |
|
Updated: Clinician Alert - Invasive group A streptococcal disease | 31 July 2023 | 15 September 2023 |
| SN:014/22 |
|
Disruption to supply – tenecteplase (Metalyse®) and alteplase (Actilyse®) injection | 5 October 2022 | 13 September 2023 |
| SN:024/23 |
|
Updated - Medication management in Parkinson disease | 1 September 2023 | 7 September 2023 |
| SN:002/20 |
|
Management of medication for patients with Parkinson disease (Supercedes SN:013/11) | 11 March 2020 | 1 September 2023 |
| SN:007/21 |
|
Assessment and care of early labour; opioid and non-opioid analgesia | 14 April 2021 | 15 August 2023 |
| SI:001/20 |
|
Use of linen in radiological procedures potential artefact | 13 January 2020 | 14 August 2023 |
| SN:022/21 |
|
Preparation of Pfizer COVID-19 vaccines | 17 September 2021 | 1 August 2023 |
| SN:017/10 |
|
Group A Streptococcal Maternal Sepsis | 24 December 2010 | 31 July 2023 |
| SA:001/23 |
|
Clinician Alert - Invasive group A streptococcal disease | 5 January 2023 | 31 July 2023 |
| SN:004/16 |
|
Assessment and management of risk of absconding from declared mental health inpatient units | 22 June 2016 | 28 July 2023 |
| SI:005/21 |
|
Reporting Adverse Events Following Immunisation | 23 May 2021 | 23 May 2023 |
| SN:009/21 |
|
Illicit cocaine containing strong opioids | 14 May 2021 | 9 May 2023 |
| SN:017/21 |
|
Illicit cocaine containing high levels of lidocaine (lignocaine) | 13 August 2021 | 4 May 2023 |
| SN:008/23 |
|
Disruption to supply: Heparin sodium (Pfizer®) 5000 units/5 mL injection ampoule | 4 April 2023 | 27 April 2023 |
| SI:002/16 |
|
Switching between Extended Release (XR) vs Immediate Release (IR) Formulations | 25 August 2016 | 19 April 2023 |
| SN:005/18 |
|
Peri-operative risk of SGLT2 inhibitor–associated ketoacidosis | 15 March 2018 | 19 April 2023 |
| SN:011/09 |
|
Allopurinol and Azathioprine | 7 May 2009 | 19 April 2023 |
| SA:004/23 |
|
Clinician alert – Measles case in NSW | 31 March 2023 | 6 April 2023 |
| SN:003/16 |
|
Use of Prone Restraint and Parenteral Medication in Healthcare Settings | 14 July 2016 | 30 March 2023 |
| SI:003/21 |
|
Paediatric stationary oxygen concentrator set-up - Absence of low flow alarm for flow rates less than 2 litres per minute | 20 May 2021 | 28 March 2023 |
| SN:010/10 |
|
Correct identification of medication and solutions for epidural anaesthesia and analgesia | 25 August 2010 | 27 February 2023 |
| SN:012/21 |
|
Enoxaparin 20 mg and 40 mg syringes: Disruption to supply | 1 June 2021 | 27 February 2023 |
| SA:008/22 |
|
Japanese Encephalitis Virus – Update for Clinicians | 16 December 2022 | 23 February 2023 |
| SN:018/22 |
|
Updated: Transvaginal mesh implants for PelvicOrgan (Vaginal) Prolapse | 24 October 2022 | 1 February 2023 |
| SI:001/23 |
|
Potential for error: look-alike fentanyl and suxamethonium Juno® ampoules | 27 January 2023 | 31 January 2023 |
| SN:006/09 |
|
Wrong Route Errors with Oral Medication | 25 March 2009 | 31 January 2023 |
| SN:005/21 |
|
HYDROmorphone (Dilaudid®) Oral Liquid 1 mg/mL – Discontinued | 17 March 2021 | 31 January 2023 |
| SA:009/22 |
|
Defect alert: Computerised Ambulatory Delivery Device (CADD) pumps. | 23 December 2022 | 12 January 2023 |
| SI:011/22 |
|
Philips Respironics CPAP and bi-level masks containing magnets | 25 November 2022 | 16 December 2022 |
| SA:002/22 |
|
Increased risk of presentation of Japanese encephalitis | 28 Feburary 2022 | 16 December 2022 |
| SN:003/06 |
|
Peiron stent fracture in renal arteries | October 2006 | 28 November 2022 |
| SN:003/21 |
|
Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) | 1 March 2021 | 11 November 2022 |
| SN:019/22 |
|
New recommendations for anticancer drug dosing in kidney dysfunction – ADDIKD guideline | 27 October 2022 | 4 November 2022 |
| SN:018/21 |
|
Myocarditis and pericarditis after mRNA COVID-19 vaccines | 18 August 2021 | 4 November 2022 |
| SN:008/22 |
|
Disruption to supply – non-ionic iodinated contrast media agents | 18 July 2022 | 27 October 2022 |
| SN:015/17 |
|
Transvaginal mesh implants for Pelvic Organ (Vaginal) Prolapse (Supersedes SN:010/17) | 20 December 2017 | 24 October 2022 |
| SA:005/22 |
|
Critical disruption to supply – tenecteplase (Metalyse®) injection - Updated | 1 September 2022 | 5 October 2022 |
| SN:012/22 |
|
Quarantine required – glass vials supplied with ANSTO Tc-99m generators | 23 September 2022 | 28 September 2022 |
| SN:014/21 |
|
25C-NBOMe toxicity in patients who used powder thought to be MDMA | 2 July 2021 | 31 August 2022 |
| SN:011/20 |
|
Heroin and cocaine containing fentanyl and acetylfentanyl | 26 November 2020 | 31 August 2022 |
| SN:009/20 |
|
Acetylfentanyl and fentanyl in non-opioid illicit drugs | 16 October 2020 | 31 August 2022 |
| SI:001/12 |
|
Antenatal magnesium sulphate infusion prior to preterm birth for neuroprotection of the foetus infant and child | 4 May 2012 | 31 August 2022 |
| SN:003/07 |
|
Creutzfeldt - Jacob Disease (CJD) Transmission During High Risk Surgical Procedures(“dorsal route ganglia” amended to read "dorsal root ganglia" - updated 20 March 07) | 19 March 2007 (revised 20 March 2007) | 5 September 2022 |
| SN:004/07 |
|
Shower Curtain and Curtain Tracks in Mental Health Facilities | 28 March 2007 | 5 September 2022 |
| SI:001/09 |
|
Drager Oxylog 2000 Transport Ventilator | 8 January 2009 | 5 September 2022 |
| SA:001/09 |
|
PEEP Valve, Expiration Diverter Assembly | 13 February 2009 | 5 September 2022 |
| SA:003/09 |
|
Draeger Medical Babylog 8000 Plus Neonatal Ventilator | 26 June 2009 | 5 September 2022 |
| SN:014/09 |
|
Retained or Broken Orthopaedic Surgical Equipment in Patients | 9 July 2009 | 5 September 2022 |
| SA:008/11 |
|
Pneumocystis jirovecii Pneumonia (PJP) in transplant patients | 19 December 2011 | 5 September 2022 |
| SI:002/12 |
|
Measles Outbreak | 31 August 2012 | 5 September 2022 |
| SA:002/17 |
|
Insufflator Gas Connectors | 12 January 2017 | 5 September 2022 |
| SN:001/17 |
|
Vaccine cold chain management in NSW Facilities | 2 February 2017 | 5 September 2022 |
| SN:011/17 |
|
Disposable Ventilator Catheter Mounts Failure | 29 September 2017 | 5 September 2022 |
| SI:001/18 |
|
ABO Compatibility for Blood Products in an Emergency | 19 June 2018 | 5 September 2022 |
| SN:015/18 |
|
Parietex composite parastomal mesh hazard alert and recall | 9 November 2018 | 5 September 2022 |
| SN:017/18 |
|
Printing the correct ECG for patients Correction to Para 2: QLD Health | 27 November 2018 | 5 September 2022 |
| SN:018/18 |
|
Newborn Self-Inflating Bag (SIB) resuscitators | 27 November 2018 | 5 September 2022 |
| SA:001/20 |
|
LIFEPAK® 15 Monitor/Defibrillator defect correction - 2020 | 14 January 2020 | 5 September 2022 |
| SN:008/21 |
|
Medtronic Covidien DAR™ airway products – Deviation in sterilisation processing | 29 April 2021 | 5 September 2022 |
| SI:006/21 |
|
Patient identity checks before administration of blood products | 21 June 2021 | 5 September 2022 |
| SA:001/22 |
|
FOOD RECALL Elecare, Similac and Alimentum infant formula | 21 Feburary 2022 | 5 September 2022 |
| SA:004/22 |
|
Critical disruption to supply – tenecteplase (Metalyse®) injection | 3 August 2022 | 1 September 2022 |
| SA:002/21 |
|
Urgent stock preservation of tocilizumab injections for COVID-19 patients required | 31 August 2021 | 29 July 2022 |
| SA:001/21 |
|
Critical disruption to the supply of tocilizumab | 9 August 2021 | 29 July 2022 |
| SN:008/20 |
|
Illicit supply of counterfeit alprazolam (Updated) | 9 September 2020 | 28 July 2022 |
| SN:015/21 |
|
Philips Sound Abatement Foam on selected sleep and respiratory devices – Product Defect Correction | 5 July 2021 | 27 July 2022 |
| SA:003/22 |
|
Critical disruption to supply - Non-ionic iodinated contrast media agents | 17 May 2022 | 18 July 2022 |
| SN:001/22 |
|
Avoiding thrombophlebitis with intravenous amiodarone | 4 March 2022 | 18 July 2022 |
| SN:024/21 |
|
Ensuring the safe and appropriate use of casirivimab and imdevimab | 7 December 2021 | 13 July 2022 |
| SN:020/21 |
|
Remdesivir 100mg injection –disruption to supply | 9 September 2021 | 13 July 2022 |
| SN:004/22 |
|
‘Sterile Theatre Pack’ formulations of lignocaine (lidocaine) with adrenaline (epinephrine) and bupivacaine with adrenaline (epinephrine) injection disruption to supply | 13 May 2022 | 07 June 2022 |
| SN:004/17 |
|
Infection post cardiopulmonary bypass associated with heater-cooler devices (Supersedes SN:007/16) | 3 March 2017 | 23 May 2022 |
| SN:001/16 |
|
Changes to Medicine Ingredient Names - April 2016 to April 2020 | 9 May 2016 | 4 May 2022 |
| SI:003/09 |
|
Varenicline (CHAMPIX)-Serious Psychiatric Side Effects | 29 May 2009 | 4 May 2022 |
| SN:004/08 |
|
Oxycodone (Revised)
Poster: Solid Oral Morphine and Oxycodone Products for Pain Relief | 16 May 2008 | 4 May 2022 |
| SA:002/14 |
| Potential bacterial contamination of propofol Update: Quarantine of Provive and Sandoz propofol all sizes and batches lifted | 2 May 2014, 15 July 2014 | 10 March 2022 |
| SI:001/06 |
|
Alaris SE pumps recall, Filshie Clip System, peanut allergies, Bisphosphonates medications | 8 September 2006 (revised 23 March 2007) | 9 March 2022 |
| SN:005/06 |
|
Safe Use of Fentanyl Skin Patches | 23 Octobter 2006 (revised 22 February 2007) | 9 March 2022 |
| SN:003/13 |
|
Voluven and Volulyte (hydroxyethyl starch) | 5 September 2013 | 9 March 2022 |
| SA:001/17 |
|
HYDROmorphone: High-risk medicine (Supersedes SA:004/11 and SN:011/10) | 10 January 2017 | 9 March 2022 |
| SN:010/19 |
|
Heparin sodium injection 5000 units/0.2mL - disruption to supply | 5 August 2019 | 9 March 2022 |
| SN:011/19 |
|
Benzylpenicillin injection – disruption to supply | 14 August 2019 | 9 March 2022 |
| SN:014/19 |
|
Ranitidine – Product Recall | 4 October 2019 | 9 March 2022 |
| SN:009/16 |
|
Avoiding thrombophlebitis with intravenous amiodarone(Supersedes Safety Notice 003/09 issued on 11 February 2009) | 29 September 2016 (revised 10 February 2017) | 3 March 2022 |
| SN:003/09 |
|
Intravenous Amiodarone | 11 February 2009 | 9 February 2017 |
| SN:008/09 |
|
Insertion of intraocular lensRecommended intraocular lens insertion process(To be read in conjunction with SN: 008/09) | 31 March 2009 | 4 January 2022 |
| SA:003/17 |
|
Infection from contaminated ultrasound gel | 12 May 2017 | 4 January 2022 |
| SA:001/18 |
|
Vaccine storage and cold chain management | 9 February 2018 | 4 January 2022 |
| SN:009/09 |
|
Acute Coronary Syndrome | 28 April 2009 | 4 January 2022 |
| SA:002/09 |
|
Guidewire Alert | 16 June 2009 | 4 January 2022 |
| SN:018/09 |
|
Reducing Incidents Involving Tracheostomy Tube CareTo be read in conjunction with SN: 018/09PD2006-098 - Tracheostomy - Unavoidable early (<72 hours) Tracheostomy Tube change | 16 September 2009 | 4 January 2022 |
| SA:006/09 |
|
Emergency/ Arrest Buttons | 4 November 2009 | 4 January 2022 |
| SA:001/10 |
|
RECALL of Unomedical - Endotracheal Tubes | 8 January 2010 | 4 January 2022 |
| SA:002/10 |
|
RECALL of Breathing Systems with Intersurgical #1986 Connector | 13 January 2010 | 4 January 2022 |
| SN:004/10 |
|
Important Changes to Medical Gas Cylinders(Superseded by Safety Notice 010/16 issued on 10 October 2016) | 22 April 2010 | 4 January 2022 |
| SI:003/13 |
|
25l-NBOMe Potent hallucinogenic substance in NSW | 4 December 2013 (revised 19 December 2013) | 4 January 2022 |
| SN:004/14 |
|
Removal of Central Venous Access Devices (CVAD) | 12 August 2014 | 4 January 2022 |
| SN:008/16 |
|
Comfort impregnated cloth topical skin products: potential for bacterial contamination | 20 September 2016 | 4 January 2022 |
| SN:011/16 |
|
Povidone Iodine for pre-operative antisepsis – Disruption to supply | 8 November 2016 (revised 21 November 2016) | 4 January 2022 |
| SN:013/16 |
|
Implantable cardiac defibrillator and cardiac resynchronization therapy defibrillator devices | 18 November 2016 | 4 January 2022 |
| SN:004/19 |
|
JJM Intraluminal Proximate Circular Stapler (ILS) | 4 April 2019 | 4 January 2022 |
| SN:020/18 |
|
Salem Sump Nasogastric Tube Shortage | 14 December 2018 | 4 January 2022 |
| SN:013/21 |
|
Changes to COVID-19 vaccine access and indications (updated) | 1 July 2021 | 16 November 2021 |
| SA:003/06 |
|
Ultravist-370 | 4 August 2006 | 3 November 2021 |
| SN:001/06 |
|
Guidant Implantable Pacemakers | 9 February 2006 | 3 November 2021 |
| SN:002/06 |
|
Cleaning of flexible endoscopes (reprocessing)(Web address for Infection Control Policy updated on 26 February 2007) | September 2006 (revised 26 February 2007) | 3 November 2021 |
| SA:003/07 |
|
Medtronic SynchroMed® EL Implantable Pump - Neurological drug delivery pumps | 12 September 2007 | 3 November 2021 |
| SI:001/07 |
|
Alcohol-Based Hand Cleansers and Fire(Has been superseded by Safety Information SI: 001/11) | 27 June 2007 | 3 November 2021 |
| SN:008/07 |
|
Electronic Fetal Heart Rate Monitoring(Has been superseded by Safety Notice SA:004/07) | 8 May 2007 | 3 November 2021 |
| SA:002/07 |
|
Communication Systems | 9 May 2007 | 3 November 2021 |
| SA:001/07 |
|
Fine Bore Nasogastric Feeding Tubes | 3 May 2007 | 3 November 2021 |
| SN:013/07 |
|
Extravasation of IV fluids: Care of the cannula site in neonates and children | 21 September 2007 | 3 November 2021 |
| SA:004/07 |
|
Electronic Fetal Heart Rate Monitoring(Supersedes Safety Notice SN:008/07) | 4 October 2007 | 3 November 2021 |
| SN:002/08 |
|
Pulmonary Embolism: Diagnosis in Young People | 29 January 2008 | 3 November 2021 |
| SA:001/08 |
|
Peripherally Inserted Central Catheter (PICC) Lines | 10 October 2008 | 3 November 2021 |
| SA:002/08 |
|
Peripherally Inserted Central Catheter (PICC) Line - Arrow 3 FG Brand(Suspension lifted 24 Dec 08) | 13 October 2008 | 3 November 2021 |
| SA:002/08 |
|
Peripherally Inserted Central Catheter (PICC) Lines(Supersedes Safety Alert SA:001/08) | 13 October 2008 | 3 November 2021 |
| SI:003/08 |
|
Whooping Cough | 3 December 2008 | 3 November 2021 |
| SN:012/08 |
|
Autonomic Dysreflexia | 16 December 2008 | 3 November 2021 |
| SN:007/09 |
|
Nasogastric Feeding Tubes for Infants and Children(Revised) | 27 March 2009 | 3 November 2021 |
| SN:014/10 |
|
Autonomic Dysreflexia(Supersedes Safety Notice 014/10 issued on 26 October 2010) | 1 November 2010 | 3 November 2021 |
| SI:001/11 |
|
Safe Use of Alcohol Based Skin Preparations for Surgical and Anaesthetic Procedures(Supersedes Safety Information SI: 001/07 issued on 27 June 2007) | 7 October 2011 | 3 November 2021 |
| SA:001/12 |
|
Product Recall CSL Human Albumin | 08 March 2012 | 3 November 2021 |
| SA:002/12 |
|
Product Recall - CSL Human Albumin - Batches Released from Quarantine (Albumex 4, Albumex 20) | 15 Mar 2012 | 3 November 2021 |
| SA:001/16 |
|
Product Recall Catheters with Beacon Tip Technology | 6 May 2016 | 3 November 2021 |
| SN:005/17 |
|
Povidone-Iodine (PVI) Use in NSW Hospitals | 19 April 2017 | 19 August 2021 |
| SN:004/21 |
|
Identification of Post-Injection Syndrome Olanzapine Pamoate Long Acting Injection | 2 March 2021 | 9 August 2021 |
| SA:001/19 |
|
enFlow Fluid Warmers - Risk of Aluminium toxicity | 13 March 2019 | 7 July 2021 |
| SN:019/09 |
|
Managing Pigtail Drains Safely | 8 October 2009 | 7 July 2021 |
| SN:011/21 |
|
Changes to COVID-19 vaccine indications | 23 May 2021 | 1 July 2021 |
| SN:003/17 |
|
Glyceryl trinitrate (GTN) tablets - disruption to supply(Supersedes SN:002/16) | 8 February 2017 | 20 May 2021 |
| SA:004/17 |
|
HYDROmorphone (high-risk medicine): Changes to Dilaudid® injectable preparations | 28 July 2017 | 20 May 2021 |
| SN:002/17 |
|
Identification of Post-Injection Syndrome Olanzapine Pamoate Long Acting Injection | 8 February 2017 | 2 March 2021 |
| SN:021/18 |
|
Discontinuation of nifedipine (twice daily products) and patient safety risks with alternative | 18 December 2018 | 18 January 2021 |
| SN:007/20 |
|
Illicit supply of counterfeit alprazolam | 16 July 2020 | 9 September 2020 |
| SN:006/19 |
|
Fentanyl 100 microg/2 mL injection – disruption to supply | 15 April 2019 | 30 July 2020 |
| SN:005/19 |
|
Lignocaine with adrenaline 1:200,000 injections – Disruption to supply and risk of patient harm | 8 April 2019 | 30 July 2020 |
| SN:002/19 |
|
Morphine sulfate 30mg/ml injection - disruption to supply(Supersedes SN:007/18) | 15 February 2019 | 30 July 2020 |
| SN:001/19 |
|
Thiopental injection (Pentothal®) disruption to supply | 17 January 2019 | 30 July 2020 |
| SN:016/18 |
|
Abnormalities with Suboxone 2/0.5 mg film | 20 November 2018 | 30 July 2020 |
| SN:011/18 |
|
New formulation: Phenytoin (Dilantin®) capsules | 15 August 2018 | 30 July 2020 |
| SI:003/11 |
|
Safe Storage of Accountable Medicines | 29 November 2011 | 30 July 2020 |
| SA:005/09 |
|
Relenza (zanamivir) Inhalation Powder Safety Advisory | 21 October 2009 | 30 July 2020 |
| SA:001/06 |
|
Baxter Infusion Pumps | 8 February 2006 | 30 July 2020 |
| SI:003/14 |
|
The Risk of Toxicity from Topical Anaesthetic Products | 18 September 2014 | 22 May 2020 |
| SN:013/11 |
|
Management of medication for patients with Parkinson’s Disease (PD) | 7 November 2011 | 10 March 2020 |
| SN:001/18 |
|
Midazolam injection 5 mg/5 mL shortage and risk of error | 5 January 2018 | 8 July 2019 |
| SN:012/17 |
|
Intravenous piperacillin-tazobactam – Disruption to supply | 20 October 2017 | 8 July 2019 |
| SN:008/17 |
|
DILAUDID® (HYDROmorphone) Oral Liquid 1 mg/mL – Disruption to Supply | 6 June 2017 | 8 July 2019 |
| SN:006/17 |
|
Dantrium (dantrolene sodium) Powder for Injection vials - Disruption to Supply | 5 April 2017 | 8 July 2019 |
| SN:014/16 |
|
Melphalan powder for intravenous infusion - Disruption to supply | 15 December 2016 | 8 July 2019 |
| SN:012/16 |
|
Aciclovir intravenous infusion preparations – Disruption to supply | 14 November 2016 (revised 13 December 2016) | 8 July 2019 |
| SA:002/16 |
|
Vancomycin Intravenous preparations – Disruption to supply | 8 December 2016 (revised 20 December 2016) | 8 July 2019 |
| SN:001/15 |
|
Suxamethonium Chloride Injection BP 100mg in 2ml - Disruption to Supply | 11 March 2015 | 8 July 2019 |
| SN:002/14 |
|
Newer Oral Anticoagulants (Update) | 24 March 2014 | 8 July 2019 |
| SI:002/14 |
|
PROPOFOL - importance of aseptic technique and safe administration practices | 26 August 2014 | 8 July 2019 |
| SN:001/12 |
|
Morphine sulfate injection 10mg/mL ampoules supply changes and toxicity issues | 17 December 2012 | 8 July 2019 |
| SN:014/11 |
|
Newer Oral Anticoagulants | 9 November 2011 | 8 July 2019 |
| SN:009/17 |
|
High Concentration Insulin Products | 5 September 2017 | 24 June 2019 |
| SN:007/18 |
|
Morphine sulfate 5 mg/1 mL and 10 mg/1 mL injection shortages(Supersedes SN:004/18) | 25 May 2018 | 15 February 2019 |
| SN:014/18 |
|
Medical Gas Adaptor | 29 October 2018 | 1 November 2018 |
| SN:004/18 |
|
Morphine sulfate injection 5 mg/1 mL shortage and risk of error | 22 February 2018 | 25 February 2018 |
| SN:007/17 |
|
Etoposide preparations - Disruption to Supply | 2 May 2017 | 29 November 17 |
| SA:003/16 |
|
Intravenous Metronidazole – Disruption to supply | 9 December 2016 | 24 February 2017 |
| SN:007/16 |
|
Surgical site infections associated with heater cooler devices | 4 August 2016 | 7 March 2017 |
| SN:006/16 |
|
Etopophos (etoposide phosphate) powder for injection vials and Vepesid (etoposide) capsules - Disruption to Supply | 27 July 2016 | 2 May 2017 |
| SN:002/16 |
|
Glyceryl trinitrate (GTN) tablets | 3 June 2016 | 8 February 2017 |
| SN:003/14 |
|
Potassium Chloride BP 10mmol/10mL ampoules disruption to supplyNote:
disruption to supply extended. | 4 August 2014 | 21 December 2016 |
| SN:004/13 |
|
Sodium BiCarbonate intravenous infusion BP 8.4% 100ml shortage | 4 September 2013 | 21 December 2016 |
| SA:001/13 |
|
Risks associated with WockhardtTM morphine sulfate injection 10mg/mL (preserved) ampoules | 1 May 2013 | 21 December 2016 |
| SA:005/12 |
|
Recall Ventolin & Asmol Inhalers - 10 batches | 24 December 2012 | 21 December 2016 |
| SN:011/11 |
|
Recall of activated Drotrecogin alfa (Xigris) | 26 October 2011 | 21 December 2016 |
| SN:007/11 |
|
BenPen™ (Benzylpenicillin) | 28 September 2011 | 21 December 2016 |
| SA:007/11 |
|
Caelyx®pegylated liposomal doxorubicin 20mg and 50mg | 5 December 2011 | 21 December 2016 |
| SA:006/11 |
| Supply of Minijet® injections | 7 October 2011 | 21 December 2016 |
| SA:004/11 |
|
HYDROmorphone: High-risk analgesic | 21 April 2011 | 10 January 2017 |
| SA:003/11 |
|
Pneumovax ®23 Injection Advice against Revaccination | 18 April 2011 | 21 December 2016 |
| SA:002/11 |
|
Recall of Pneumovax ®23 Injection (pneumococcal polyvalent, MSD 0.5ml Vial AUST R 10507; CSL code 0786100110 pack vials) Batch No. N3336, expiry date 22 June 2011 | 25 March 2011 | 21 December 2016 |
| SN:011/10 |
|
Medication Incidents Involving Hydromorphone (Opioid)(To be read in conjunction with
SA:004/11) | 14 September 2010 (revised 16 September 2010) | 10 January 2017 |
| SA:006/10 |
|
Recall of Sitaxentan (Thelin) | 10 December 2010 | 21 December 2016 |
| SA:005/10 |
|
Extreme Caution - Esmolol hydrochloride 2500mg in 10ml for injection | 25 June 2010 | 21 December 2016 |
| SA:007/09 |
|
Recall of Cefazolin Sandoz BATCH AH 5067 | 6 November 2009 | 21 December 2016 |
| SA:004/09 |
|
New Version of Adult National Inpatient Medication Chart [NIMC] - SMR140 | 16 September 2009 | 21 December 2016 |
| SN:008/08 |
|
Clexane | 16 May 2008 | 21 December 2016 |
| SI:002/08 |
|
Zolpidem (“Stilnox”) | 19 June 2008 | 8 February 2018 |
| SI:001/08 |
|
Paracetamol | 4 June 2008 | 8 February 2018 |
| SN:006/07 |
|
Warfarin | 12 April 2007 (revised 18 January 2008) | 8 February 2018 |
| SA:004/06 |
|
Safe Use of Vincristine | 8 February 2006 | 8 February 2018 |